Unilever Indonesia’s 3Cs turnaround, stabilizing volumes and 12%+ yield offer asymmetric recovery potential, but execution must reverse market-share losses and defend margins against agile local competitors.
PT Unilever Indonesia Tbk (UNVR.JK) operates as one of the premier fast-moving consumer goods (FMCG) enterprises in Indonesia [cite: 1, 2]. Established on December 5, 1933, and publicly listed on the Indonesia Stock Exchange (IDX) in 1982 [cite: 1], the company functions as an operating subsidiary of global consumer group Unilever PLC, which retains an 85.37% majority stake through Unilever Indonesia Holding B.V. [cite: 3]. The firm manufactures, markets, and distributes personal care, home care, and food products across the entirety of the Indonesian archipelago [cite: 1, 3].
The business generates its top-line revenue through two primary reporting segments: Home & Personal Care (HPC), which contributes approximately 63.5% to 67.0% of net sales, and Foods & Refreshment (F&R), which accounts for the remaining 33.0% to 36.5% [cite: 2, 3]. In the fiscal year 2025, continuing operations generated net sales of Rp 31.9 Trillion [cite: 4, 5]. This top-line figure reflects extensive strategic portfolio reshaping, highlighted by the divestment of the ice cream unit for Rp 7 Trillion and the sale of non-core tea assets (SariWangi) for Rp 1.5 Trillion [cite: 2, 6].
The commercial infrastructure relies on an extensive route-to-market model supported by 34 central distribution depots, over 800 direct distributor partners, and a physical supply footprint that services between 3.2 million and 3.5 million retail sales outlets nationwide [cite: 1, 2, 4]. Through this distribution infrastructure, the enterprise achieves an estimated 100% household penetration in Indonesia, meaning virtually every domestic household purchases at least one of its stock keeping units (SKUs) annually [cite: 4].
| Segment Dimension | Home & Personal Care (HPC) | Foods & Refreshment (F&R) |
|---|---|---|
| Revenue Contribution (% Net Sales) | ~63.5% – 67.0% [cite: 2, 3] | ~33.0% – 36.5% [cite: 2, 3] |
| Primary Brands | Lifebuoy, Pepsodent, Vaseline, Sunsilk, Dove, Rinso, Sunlight, Glow & Lovely, Rexona [cite: 1, 2, 3, 4] | Royco, Bango, Knorr, Buavita [cite: 1, 2, 3] |
| Key Product Categories | Oral Care, Skin Cleansing, Skin Care, Hair Care, Deodorants, Fabric Cleaning, Dishwashing [cite: 3, 7] | Cooking Aids, Seasonings, Soy Sauce, Packaged Fruit Juices [cite: 3, 7] |
| Primary Customer Segments | Mass-market & Premium domestic consumers across urban, suburban, and rural regions [cite: 4, 8] | Household kitchens, commercial food service (Unilever Food Solutions), and HORECA [cite: 2, 3] |
| Distribution Channels | General Trade (GT / Warungs), Modern Trade (MT / Minimarkets, Supermarkets), E-commerce [cite: 2, 9] | GT, MT, B2B Food Service Channels, Digital Marketplaces [cite: 2, 9] |
Consumers select the company's product portfolio over domestic and multinational alternatives due to brand equity built over more than nine decades [cite: 4, 10], localized product formulations tailored to Indonesian cultural preferences [cite: 1, 8], tiered price architecture (extending from single-use micro-sachets for traditional trade to bulk formats for modern channels) [cite: 8], and universal retail availability across traditional and modern trade networks [cite: 2, 4].
The underlying revenue trajectory for the business depends on three primary operational levers: underlying volume growth (UVG), underlying price realization (UPG), and channel mix optimization [cite: 2, 11, 12]. Historical expansion relied heavily on gross margin expansion and pricing power; however, market fragmentation, rising raw material costs, and shifts in consumer buying behavior have necessitated a comprehensive strategic pivot toward volume-led growth, operational cost control, and digital distribution transformation [cite: 2, 10, 13].
The corporate turnaround strategy is built around the "3Cs" operational framework [cite: 2]:
* Category Focus: Reallocating capital, research and development, and marketing investments toward fast-growing, higher-margin "Market Maker" SKUs within Beauty & Wellbeing, Personal Care, and Home Care [cite: 2]. The divestment of the lower-margin, capital-intensive ice cream business (Rp 7 Trillion asset value) and the tea business (SariWangi for Rp 1.5 Trillion) aligns directly with this initiative to create an asset-light corporate structure [cite: 2, 6].
* Channel Transformation: Executing the "More Stores, Better Stores" initiative while upgrading distributor operations via Distributor Digital Transformation (DT) [cite: 2]. This transformation minimizes inventory bullwhip distortion, stabilizes wholesale trade pricing, and improves point-of-sale execution across general trade outlets [cite: 2].
* Cost Productivity: Automating manufacturing operations across its 9 domestic factories, streamlining corporate overhead, and optimizing raw material procurement to expand gross margins toward a long-term target of 50% [cite: 1, 2].
The structural economic moat protecting the enterprise is moderate, having experienced localized attrition over recent years while maintaining structural strengths [cite: 10]:
* Distribution Network Advantage (Wide Moat): Managing an integrated distribution structure that directly accesses 3.2 million to 3.5 million retail outlets across 17,000 islands creates a substantial barrier to entry [cite: 2, 4, 9]. The route-to-market logistics density achieved by the company is difficult for emerging competitors to replicate cost-effectively [cite: 9].
* Brand Equity & Intangible Assets (Narrow Moat): Legacy household names such as Lifebuoy, Pepsodent, Rinso, and Royco hold dominant market share positions across nine primary FMCG categories [cite: 1, 4]. However, brand equity has faced pressure due to localized consumer boycott sentiment in 2023–2024 and rising consumer willingness to substitute with domestic indie brands [cite: 9, 10, 14].
* Manufacturing Scale Economies (Narrow Moat): Operating 9 localized production facilities enables significant procurement leverage in raw materials and spreads fixed overhead over a massive volume base [cite: 1, 2, 10].
* Switching Costs (None): Switching costs for end consumers in the retail consumer staples sector are non-existent. Brand adherence depends on perceived value, consistent product performance, and point-of-sale visibility [cite: 9].
Indonesia represents the largest market for beauty, personal care, and household goods in Southeast Asia [cite: 9]. Industry benchmark data shows that the Indonesian Beauty & Personal Care market alone reached USD 9.74 Billion in 2025 and is projected to compound at a 4.35% CAGR to reach USD 12.58 Billion by 2031 [cite: 9]. Niche product lines, such as home water purification systems (Pureit), are expanding at a 7.5% projected CAGR [cite: 15]. The expansion of this Total Addressable Market (TAM) is driven by favorable demographics, urbanization, expanding digital commerce penetration (19.9% online share in beauty), and rising per-capita income [cite: 8, 9].
The competitive environment in Indonesia has intensified across both traditional and modern trade channels [cite: 10]. The enterprise faces dual competition from agile domestic manufacturers and focused global FMCG peers [cite: 9, 10, 14]:
| Competitor / Entity | Core Category Focus | Competitive Position vs. UNVR.JK | Market Share Momentum |
|---|---|---|---|
| PT Paragon Technology & Innovation | Wardah, Make Over, Kahf (Skincare & Cosmetics) | Leader in Halal-certified cosmetics; highly responsive domestic supply chain [cite: 9] | Gaining market share in Personal Care & Skincare [cite: 9, 14] |
| Wings Group | Daia, So Klin, Giv, Nuvo (Fabric & Personal Wash) | Value-priced positioning targeting lower-middle income demographics [cite: 10, 14] | Holding/Gaining ground in Home Care [cite: 10, 14] |
| Indofood CBP / Mayora Indah | Indomie, Royco rival seasonings, packaged foods | Dominant distribution in food service and packaged foods with regional R&D [cite: 10] | Holding ground in Foods segment [cite: 10] |
| Procter & Gamble (P&G) / Colgate | Pantene, Head & Shoulders, Oral Care | Premium positioning in modern urban channels [cite: 6] | Holding ground in urban Modern Trade [cite: 2] |
| Victoria Care / KINO Indonesia | Herborist, Ellips, Personal Care | Rapid-launch indie beauty products tailored for social commerce [cite: 9, 10] | Gaining in e-commerce & social commerce channels [cite: 9] |
Overall market share by value declined from historical levels above 38.5% in 2023 down to approximately 33.0%–34.9% in late 2024/2025 as a result of consumer boycotts and price competition [cite: 2, 9]. Recent operational updates confirm that market share is stabilizing as trade price adjustments and channel initiatives take hold [cite: 2, 16].
The latest reported financial performance reflects results for the First Half of Fiscal Year 2026 (H1 2026), released on July 28, 2026 [cite: 4].
For H1 2026, the company generated cumulative Net Sales of Rp 16.90 Trillion [cite: 6]. Quarterly breakdowns show Q1 2026 sales of Rp 8.44 Trillion and Q2 2026 sales of Rp 8.46 Trillion [cite: 17]. Net income reached Rp 2.14 Trillion in Q1 2026 and Rp 829.10 Billion in Q2 2026, delivering H1 2026 total net profit of Rp 2.97 Trillion [cite: 6, 17].
| Metric (IDR) | Q1 2026 | Q2 2026 | H1 2026 Cumulative | Operational Context |
|---|---|---|---|---|
| Net Sales | Rp 8.44 Trillion [cite: 17] | Rp 8.46 Trillion [cite: 17] | Rp 16.90 Trillion [cite: 6] | Top-line sequential stabilization post-divestments [cite: 6, 16] |
| Cost of Revenue | Rp 4.37 Trillion [cite: 17] | Rp 4.65 Trillion [cite: 17] | Rp 9.02 Trillion [cite: 17] | Gross margin maintained in the ~46.6%–48.2% range [cite: 2, 17] |
| Operating Income | Rp 1.57 Trillion [cite: 17] | Rp 1.02 Trillion [cite: 17] | Rp 2.59 Trillion [cite: 17] | Q2 impacted by elevated brand marketing investments [cite: 17] |
| Net Income | Rp 2.14 Trillion [cite: 17] | Rp 829.10 Billion [cite: 17] | Rp 2.97 Trillion [cite: 17] | Q1 supported by non-operating gain recognition [cite: 17] |
| Earnings Per Share (EPS) | Rp 33.00 [cite: 17] | Rp 22.00 [cite: 17] | Rp 55.00 [cite: 17] | Trailing 12-month EPS estimated at Rp 91.00 – Rp 98.17 [cite: 3, 18] |
Reported H1 2026 revenue met consensus estimates, signaling operational recovery following disruptions in FY2024 and FY2025 [cite: 2, 10]. Local operational results highlighted an underlying sales growth (USG) of +7.0% in Indonesia, led by strong volume recoveries in Home Care and Beauty & Wellbeing [cite: 16].
Executive management reconfirmed full-year guidance for 2026, reiterating expectations for underlying sales growth within the 4.0% to 6.0% multi-year target range, accompanied by modest operating margin expansion [cite: 12]. Management noted that the completed divestment of the ice cream and tea divisions successfully removed seasonal earnings volatility while structural cost reductions are supporting gross margins [cite: 2, 6].
Following the H1 2026 earnings release and portfolio realignment, sell-side equity analysts remain divided [cite: 3, 19]:
* JPMorgan maintained a "Sell" rating while raising its price target from IDR 1,060 to IDR 1,240, citing cost inflation risks and domestic competition [cite: 3].
* CLSA maintained a "Hold" rating with a target price of IDR 2,100 [cite: 3].
* HSBC upgraded the stock to a "Buy" rating with a price target of IDR 2,400, highlighting historically low valuation multiples, a dividend yield above 12%, and volume recovery [cite: 3, 20].
* Ajaib Securities initiated coverage with a "Buy" rating and a price target of IDR 3,100, citing gross margin recovery and capital-light execution [cite: 2].
Historical sales performance over the 2020–2025 period reflects structural contraction, displaying a 5-year sales growth CAGR of -7.24% [cite: 21]. Consolidated sales declined from Rp 42.9 Trillion in 2020 to Rp 31.9 Trillion in 2025 (continuing operations) due to strategic asset sales, trade destocking, and market share losses [cite: 4, 5, 10, 22].
| Valuation Metric | Current Reported Value | Sector Benchmark / Peer Average | Valuation Context |
|---|---|---|---|
| Current Stock Price | IDR 1,295 [cite: 3, 17] | N/A | Trading near the lower end of 52-week range (IDR 1,295 – IDR 2,840) [cite: 3, 17] |
| Market Capitalization | Rp 49.40 Trillion [cite: 17] | N/A | Based on 38.15 Billion total ordinary shares outstanding [cite: 17] |
| Trailing P/E Ratio | 13.2x – 15.2x [cite: 3, 18] | 10.9x Sector / 8.5x Peers [cite: 3] | Discounted relative to 5-year historical average P/E of ~26.0x–30.0x [cite: 2] |
| Forward P/E Ratio | 7.0x – 14.18x [cite: 1, 3, 18] | 10.5x Sector Average | Reflects market pricing of earnings recovery risks |
| Price-to-Book (P/B) | 17.5x – 20.5x [cite: 3, 18] | 1.5x Sector / 1.7x Peers [cite: 3] | Elevated due to capital-light asset structure and ~100% dividend payout [cite: 2, 10] |
| Forward Dividend Yield | 12.45% – 14.50% [cite: 3, 20] | ~3.5% Sector Average | High yield backed by asset-light capital requirements [cite: 2, 20] |
| Enterprise Value / Sales | 1.6x – 1.87x [cite: 3, 18] | 0.8x Sector / 0.8x Peers [cite: 3] | Implied EV stands at approximately Rp 60.72 Trillion [cite: 18] |
| Risk Vector | What Could Go Wrong | Early Warning Signs | Long-Term Thesis Impact |
|---|---|---|---|
| Market Share Erosion | Inability to defend personal care market share against local indie brands [cite: 9, 14]. | Market share falling below 30.0% in quarterly store audits [cite: 2, 9]. | Permanent reduction in pricing power and structural margin compression. |
| Currency & Input Cost Inflation | Severe IDR depreciation (>Rp 17,000/USD) elevating raw material costs [cite: 10]. | Consolidated gross profit margin declining below 43.0% [cite: 2]. | Earnings contraction and forced reduction of dividend payouts [cite: 10]. |
| Distribution Disruption | Operational friction during digital route-to-market shifts [cite: 2]. | Inventory turnover days exceeding 60 days at distribution hubs [cite: 2, 10]. | Loss of general trade market reach and distributor relationship impairment. |
The 5-year quantitative model projects potential total return trajectories from FY2025/2026 through FY2030 based on explicit operating drivers. All metrics and share prices are presented in Indonesian Rupiah (IDR).
| Scenario | Current Price | Year 1 (FY2026) | Year 2 (FY2027) | Year 3 (FY2028) | Year 4 (FY2029) | Year 5 (FY2030) |
|---|---|---|---|---|---|---|
| High Case | IDR 1,295 [cite: 3] | IDR 1,600 | IDR 2,050 | IDR 2,600 | IDR 3,250 | IDR 3,962 |
| Base Case | IDR 1,295 [cite: 3] | IDR 1,420 | IDR 1,580 | IDR 1,750 | IDR 1,910 | IDR 2,084 |
| Low Case | IDR 1,295 [cite: 3] | IDR 1,200 | IDR 1,110 | IDR 1,020 | IDR 940 | IDR 871 |
$\text{Weighted Target Price} = (0.25 \times 3,962) + (0.55 \times 2,084) + (0.20 \times 871)$
$\text{Weighted Target Price} = \text{IDR } 990.50 + \text{IDR } 1,146.20 + \text{IDR } 174.20 = \mathbf{\text{IDR } 2,311}$
The probability-weighted valuation indicates a 5-year target price of IDR 2,311, representing an upside potential of 78.5% over the current share price of IDR 1,295 [cite: 3, 17].
| Scenario | Revenue / key scale metric in Year 5 | Margin / earnings assumption | Valuation multiple assumption | Current share price | Implied future share price | 5-year total return | Annualized return | Probability |
|---|---|---|---|---|---|---|---|---|
| High Case | Rp 45.79 Trillion [cite: 4, 9] | 15.0% Net Margin / EPS IDR 180.08 | 22.0x P/E Multiple [cite: 2] | IDR 1,295 [cite: 3] | IDR 3,962 | +263.8% | 28.7% | 25% |
| Base Case | Rp 39.75 Trillion [cite: 4, 9] | 12.5% Net Margin / EPS IDR 130.28 | 16.0x P/E Multiple | IDR 1,295 [cite: 3] | IDR 2,084 | +101.1% | 15.0% | 55% |
| Low Case | Rp 33.53 Trillion [cite: 10] | 9.0% Net Margin / EPS IDR 79.16 [cite: 10] | 11.0x P/E Multiple | IDR 1,295 [cite: 3] | IDR 871 | -12.7% | -7.6% | 20% |
ASYMMETRIC RECOVERY POTENTIAL
| Metric | Score (1–10) | Narrative Rationale |
|---|---|---|
| Management Alignment | 7 / 10 | High strategic alignment with parent company Unilever PLC (85.37% majority shareholder) [cite: 3]. Executive incentive structures are tied to volume expansion and operating margin metrics [cite: 13, 23]. |
| Revenue Quality | 6 / 10 | Essential consumer staples generate recurring revenue across 100% of Indonesian households [cite: 4]. Score is tempered by historical top-line sales contractions over the 2020–2025 period [cite: 10, 21]. |
| Market Position | 6 / 10 | Holds leading positions across 9 product categories [cite: 4], but overall value market share declined from >38.5% to ~33.0%–34.9% due to pressure from agile domestic competitors [cite: 2, 9, 14]. |
| Growth Outlook | 5 / 10 | Supported by broader market growth in Indonesian cosmetics and personal care (4.35% CAGR) [cite: 9]. Volume expansion depends on executing premiumization in Beauty & Personal Care [cite: 2]. |
| Financial Health | 7 / 10 | Strong operating cash flow generation with minimal long-term debt debt-service obligations [cite: 2, 3]. Liquidity remains tight (current ratio < 0.50x) due to high dividend payouts [cite: 10, 22]. |
| Business Viability | 8 / 10 | Strong operational durability backed by a 90+ year history in Indonesia [cite: 4], extensive domestic manufacturing facilities, and route-to-market distribution access [cite: 1, 4]. |
| Capital Allocation | 8 / 10 | Disciplined capital return policy featuring near 100% dividend payout ratios, share buybacks [cite: 2], asset-light capital expenditure (~2% of sales) [cite: 2], and divestment of non-core assets [cite: 2, 6]. |
| Analyst Sentiment | 6 / 10 | Equity research consensus remains divided [cite: 19]. Ratings range from cautious Sell recommendations (JPMorgan TP IDR 1,240) [cite: 3] to bullish Buy ratings (HSBC TP IDR 2,400; Ajaib TP IDR 3,100) [cite: 2, 3]. |
| Profitability | 7 / 10 | Strong gross margins (~48.5%+) [cite: 2] and asset efficiency. Net margins compressed from historical highs due to input cost inflation and competitive trade spend [cite: 10]. |
| Track Record | 6 / 10 | Multi-decade history of dividend distributions [cite: 20, 24] offset by equity value contraction over the last five years (-73.4% 5-year return) [cite: 3, 18]. |
TRANSFORMATION IN PROGRESS
PT Unilever Indonesia Tbk (UNVR.JK) occupies a key position within Indonesia's fast-moving consumer goods sector [cite: 1, 2]. Following five years of revenue contraction and market share pressures stemming from domestic competition and consumer boycotts [cite: 9, 10, 14, 21], the business is executing a strategic turnaround [cite: 2].
The divestments of the ice cream unit (Rp 7 Trillion) and non-core tea operations (SariWangi for Rp 1.5 Trillion) simplify the corporate structure, elevate underlying gross margins, and allow capital to be deployed into higher-margin segments in Beauty & Personal Care [cite: 2, 6]. The company's distribution network (reaching 3.2M–3.5M outlets) provides a route-to-market advantage that remains difficult for smaller domestic competitors to replicate nationwide [cite: 2, 4].
At a share price of IDR 1,295, the stock trades near its 52-week low at a forward P/E multiple of ~13.2x–14.2x [cite: 3, 18], compared to its 5-year historical average P/E of ~26.0x–30.0x [cite: 2]. Supported by a forward dividend yield exceeding 12% [cite: 3, 20], market valuations reflect conservative operational expectations, creating an asymmetric risk/reward profile as volume performance stabilizes [cite: 2, 16].
VALUATION REBOUND OPPORTUNITY
PT Unilever Indonesia Tbk (UNVR.JK) trades at IDR 1,295 [cite: 3, 17], near the lower bound of its 52-week range (IDR 1,295 – IDR 2,840) [cite: 3, 17]. The stock continues to trade below its 200-day simple moving average following a multi-year downtrend (-73.4% over 5 years) [cite: 3, 18]. However, the 14-day Relative Strength Index (RSI) stands at 18.53, signaling oversold technical conditions [cite: 3]. Recent corporate disclosures regarding portfolio transformation and quarterly top-line stabilization suggest short-term base building, with technical chart resistance situated near the IDR 1,590–1,615 level [cite: 1, 2, 6, 18].
OVERSOLD BASE BUILDING
View PT Unilever Indonesia Tbk (UNVR.JK) stock page
Loading the interactive version of this report…